7 Results
NIAID-Funded Study Traces Evolution of Malaria Drug Resistance in E. Africa
A new NIAID-funded study shows how inconsistent malaria control measures in East Africa could be aiding the emergence of drug-resistant mutations in the primary parasite that causes malaria.
NIAID-led Work Identifies Bacteria Signaling for Nerve Repair in Mice
A team of NIAID-led researchers has identified a mechanism in mice in which the immune system and commensal bacteria help repair damaged sensory neurons within the skin. They hope their findings could lead to therapies that stimulate recovery in people following skin injury and limit damage from chemotherapy and chronic diseases.
Candida auris—a mysterious and tenacious enemy
Candida auris, is an emerging healthcare-associated infection of growing public health concern. NIAID supports several researchers who are asking fundamental questions about the biology of C. auris. Today’s NIAID Now post features insights from NIAID-funded researchers, Jeniel Nett, M.D., Ph.D., associate professor of medicine and medical microbiology and immunology at University of Wisconsin-Madison, and Christina Cuomo, Ph.D., associate director of the Genomic Center of Infectious Diseases at the Broad Institute of Massachusetts Institute of Technology and Harvard University.
NIAID Scientists Identify New, Rapid Response to Bacterial Skin Infection
A new study in mice from NIAID scientists now shows that toxins from Staphylococcus aureus alarm the immune system hours earlier than previously known.
NIAID Observes World Antimicrobial Awareness Week 2021
Antimicrobials such as antibiotics, antivirals, and antifungal drugs are crucial tools in the fight against disease-causing microbes. However, resistance of microbes to these life-saving medicines is a growing global public health dilemma. In fact, the Centers for Disease Control and Prevention (CDC) reports that more than 2.8 million infections and over 35,000 deaths are caused by antibiotic...
Oral Probiotic Bacillus Prevents Enterococcal Sepsis in Mouse Study
A new study from NIAID's Intramural research program provides an update on research into using a probiotic to treat bacterial gut infections.
Childhood Pneumonia Study Shows Short-Course Antibiotics Superior to Standard of Care
A NIAID-sponsored study has shown that short-course antibiotic treatment is superior to standard treatment of community-acquired pneumonia in children.
